Literature DB >> 30996605

Evidence for clinicians: Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Iliana Ortega1.   

Abstract

Entities:  

Year:  2018        PMID： 30996605      PMCID： PMC6462132          DOI： 10.1093/pch/pxy156

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  16 in total

1.  Ten years of antipsychotic prescribing to children: a Canadian population-based study.

Authors:  Silvia Alessi-Severini; Robert G Biscontri; David M Collins; Jitender Sareen; Murray W Enns
Journal:  Can J Psychiatry       Date:  2012-01       Impact factor: 4.356

2.  First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Authors:  Constadina Panagiotopoulos; Rebecca Ronsley; Dean Elbe; Jana Davidson; Derryck H Smith
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

3.  Trends in the use of typical and atypical antipsychotics in children and adolescents.

Authors:  Nick C Patel; M Lynn Crismon; Kimberly Hoagwood; Michael T Johnsrud; Karen L Rascati; James P Wilson; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-06       Impact factor: 8.829

Review 4.  Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tamara Pringsheim; Darren Lam; Heidi Ching; Scott Patten
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  Trends in prescribing of antipsychotic medications for US children.

Authors:  William O Cooper; Patrick G Arbogast; Hua Ding; Gerald B Hickson; D Catherine Fuchs; Wayne A Ray
Journal:  Ambul Pediatr       Date:  2006 Mar-Apr

6.  Metabolic screening in children receiving antipsychotic drug treatment.

Authors:  Elaine H Morrato; Ginger E Nicol; David Maahs; Benjamin G Druss; Daniel M Hartung; Robert J Valuck; Elizabeth Campagna; John W Newcomer
Journal:  Arch Pediatr Adolesc Med       Date:  2010-04

7.  The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009.

Authors:  Tamara Pringsheim; Darren Lam; Scott B Patten
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

Review 8.  Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.

Authors:  M De Hert; M Dobbelaere; E M Sheridan; D Cohen; C U Correll
Journal:  Eur Psychiatry       Date:  2011-02-03       Impact factor: 5.361

Review 9.  No health without mental health.

Authors:  Martin Prince; Vikram Patel; Shekhar Saxena; Mario Maj; Joanna Maselko; Michael R Phillips; Atif Rahman
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

10.  Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years.

Authors:  Tamison Doey; Kenneth Handelman; Jamie A Seabrook; Margaret Steele
Journal:  Can J Psychiatry       Date:  2007-06       Impact factor: 4.356
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.